Company profilePharmaceutical#144 of 1,318 in Pakistan1 DRAP alert

BLOOM PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 118 brands · 128 molecules

Ranked #29 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

118 registered products 74 pharmaceutical brands 128 distinct molecules 1 DRAP alert

Company overview

118
registered products
74
pharmaceutical brands
128
distinct molecules
12
therapeutic classes
1
DRAP alerts

BLOOM PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 118 product registrations across 128 distinct molecules. It is the 144th largest registrant in Pakistan by product count, and ranks 29th of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antiemetics & Antinauseants. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by BLOOM

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Gastro 1

Top molecules by brand count

Thiamine8 brands
Pyridoxine8 brands
Riboflavin8 brands
Nicotinamide7 brands
Paracetamol6 brands
Diclofenac5 brands
Folic Acid5 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 7Antiemetics & Antinauseants · 5Antianemic, Iron & All Combination · 4Gynaecological Anti-Infective & Antiseptics · 3Antithrombotic Agents · 2Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 2Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 2Beta-Lactam Antibacterials, Penicillins · 1Macrolides, Lincosamides And Streptogramins · 1Vitamin A, D & Combinations · 1Antianemic, Iron Preparations · 1Antidepressants · 1

Regulatory record

1 alert in the DRAP feed we track.

Drug Product Recall: Blomox Forte Suspension (Batch #PF-045) by M/s Bloom Pharmaceuticals
2021-10-21

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
MEDICRAFT PHARMACEUTICALS (PVT) LTD. holds 2 molecules not in this portfolio
CalciumOlanzapine
Albro Pharmaceuticals holds 21 molecules not in this portfolio
AdapaleneAdapleneBetamethasoneClindamycinClioquinolDesloratadine

Get the full profile for BLOOM

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.